in

Animal flu and COVID-19 combination vaccine trial

Butanvac – the first COVID-19 vaccine developed by Brazilian scientists – is in clinical trials and has been shown to be effective against both the common cold and COVID-19.

download 13 1

On March 3, the Butantan Institute of Sao Paulo, one of Brazil’s most prestigious medical institutions, said the country’s research into a combined flu and COVID-19 vaccine had yielded “promising results.” “.” in animal testing.

The Butantan Institute expects further human trials to take up to a year.

Paulo Lee Ho, a researcher at the Butanvac Institute, said the Butanvac vaccine, the first COVID-19 vaccine developed by Brazilian scientists themselves, is currently in clinical trials and has been shown to be effective. . Against common flu and COVID-19.

[Comparing the complications of COVID-19 and the common flu]

In addition, Butanvac could help provide a stronger, longer-lasting immune response than the vaccines currently available in the world.

Brazil has recorded more than 650,000 deaths from COVID-19 and nearly 29 million cases of the disease in the past two years, making it the hardest-hit country along with the United States and India. popularity. coronavirus disease.

Brazil began vaccinating against COVID-19 on January 17, 2021, and to date, about 80% of the country’s 213 million people have received at least one dose of the vaccine, while about 73% have completed the program. After vaccination, 30% received a booster dose.

images 7

The world emits 3 million masks every minute, and the garbage mountain becomes a ticking time bomb

covid test 2021 600x315 1

What should F0 eat and avoid after COVID-19 treatment?